Collectively, CAFs‐derived exosomal miR‐3126‐5p facilitated glycolysis to accelerate in vivo NSCLC growth through repressing KLF13 expression and the PI3K/AKT pathway. Here, KLF13 is linked to non-small cell lung carcinoma.